Cargando…

Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease

Detalles Bibliográficos
Autores principales:	Inderhaug, CR, Murillo, LS, Webber, MJ, Callagy, GM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284893/ http://dx.doi.org/10.1186/bcr2290

Ejemplares similares

Prognostic Significance of Deregulated Dicer Expression in Breast Cancer
por: Caffrey, Emer, et al.
Publicado: (2013)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

Genetic markers in clinical subtypes of juvenile idiopathic arthritis
por: Le Blay, Pierre, et al.
Publicado: (2011)

Metabolic transformations in breast cancer subtypes
por: Mitra, Devina, et al.
Publicado: (2014)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
por: Sznol, Mario, et al.
Publicado: (2015)

Identification of molecular subtypes within a formalin-fixed, paraffin-embedded breast cancer tumour cohort
por: Mulligan, JM, et al.
Publicado: (2010)

Reproducibility of molecular portraits in early stage breast cancer
por: Nuyten, DSA, et al.
Publicado: (2005)

Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma
por: Forghanifard, Mohammad M, et al.
Publicado: (2010)

A critical need for molecular markers of breast cancer risk and risk reduction
por: Johnson, KA, et al.
Publicado: (2005)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Ductal carcinoma in situ (DCIS): the role of prognostic indicators in informing treatment and reducing local recurrence
por: Clements, K, et al.
Publicado: (2004)

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
por: Callagy, Grace M, et al.
Publicado: (2008)

Negative predictive value for atypia and malignancy of 14-gauge core biopsy of breast papillomas
por: Mataka, GT, et al.
Publicado: (2010)

Molecular epidemiology of HIV-1 subtype B in the Basque Country (Spain)
por: Patiño, Juan Angel, et al.
Publicado: (2012)

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
por: Amir, E, et al.
Publicado: (2009)

An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers
por: Perera, IT, et al.
Publicado: (2010)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Radiological characteristics of screen-detected lung cancers: predictive for histological subtype?
por: Heuvelmans, MA, et al.
Publicado: (2014)

An audit of women attending for technical repeat mammography at the South West London Breast Screening Service between 1991 and 2004
por: Morris, CM, et al.
Publicado: (2006)

Breast histoscanning: the development of a novel technique to improve tissue characterization during breast ultrasound
por: Wilkinson, LS, et al.
Publicado: (2010)

Hypermethylation of cyclin D(2 )and DAP kinase is associated with the lobular subtype of breast cancer
por: Lehmann, U, et al.
Publicado: (2005)

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
por: Bouchalova, K, et al.
Publicado: (2011)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

Surrogate markers of pulmonary edema and severity of lung injury do not accurately reflect measured extravascular lung water
por: LeTourneau, JL, et al.
Publicado: (2008)

Imaging features of male breast cancer: a pictorial review
por: Lloyd, CR, et al.
Publicado: (2008)

Inhibition of apoptosis by Notch signalling in breast epithelial cells
por: Meurette, O, et al.
Publicado: (2008)

An audit of women attending for symptomatic recall following routine NHSBSP screening at the South West London Breast Screening Service between 1991 and 2004
por: Morris, CM, et al.
Publicado: (2006)

Deep sequencing reveals an association between HIV-1 subtype C mutations in gp41 MPER epitopes and mother-to-child transmission
por: Yin, L, et al.
Publicado: (2012)

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value
por: Ciruelos, E, et al.
Publicado: (2011)

Incidence and outcome of 18-fluorodeoxyglucose positron emission tomography/computed tomography-detected breast lesions
por: Haine, LS, et al.
Publicado: (2011)

Compliance with the implementation of an ICU cluster-randomized trial assessing the benefits and potential harms of universal glove and gowning
por: Kett, D, et al.
Publicado: (2013)

Mammographic tumour features can reliably predict the long-term outcome of women with 1–14 mm invasive breast cancer: suggestions for revision of current therapeutic practice and the TNM classification system
por: Tabar, L, et al.
Publicado: (2004)

IL-8 is a novel marker for breast cancer
por: Chavey, C, et al.
Publicado: (2005)

Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™
por: Skippage, PL, et al.
Publicado: (2009)

Predicting the presence of invasive carcinoma from the extent of mammographic malignant microcalcification and grade of ductal carcinoma in situ on core biopsy: results from a National Health Service Screening Programme
por: O'Flynn, EAM, et al.
Publicado: (2008)

P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones
por: Siddiqui, AA, et al.
Publicado: (2009)

Unique molecular features of the HIV-1 subtype C enhancer and core promoter and their influence on the viral gene expression
por: Verma, Anjali, et al.
Publicado: (2013)

Interpretation of mammographic breast microcalcification: interobserver variability between radiologists and mammographers and analysis of best mammographic predictors of histopathological outcomes
por: Naidu, LS, et al.
Publicado: (2006)

Comparative expressed sequence hybridisation revealed distinct chromosomal regions of differential gene expression in breast cancer subtypes
por: Vanden Bempt, I, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_sbdcltjlop9n868uck7dul3hg7